<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03188770</url>
  </required_header>
  <id_info>
    <org_study_id>PRoVENT-iMIC</org_study_id>
    <nct_id>NCT03188770</nct_id>
  </id_info>
  <brief_title>Practice of Ventilation in Middle-Income Countries</brief_title>
  <acronym>PRoVENT-iMIC</acronym>
  <official_title>PRactice of VENTilation in Critically Ill Patients in Middle-Income Countries (PRoVENT-iMIC) - an International Multicenter Service Review Focusing on ICUs in Asia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mahidol Oxford Tropical Medicine Research Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this international, multicenter service review is to describe and compare
      ventilation management in patients at risk of acute respiratory distress syndrome (ARDS)
      versus patients not at risk and patients with established ARDS, and to ascertain whether
      certain ventilator settings and ventilation parameters are associated with pulmonary
      complications or development of ARDS after start of ventilation in patients in intensive care
      units (ICUs) in Asian countries.

      Participating centers will include adult patients undergoing mechanical ventilation in the
      ICU during a 28-day period. Patients' data will be collected during the first 7 days in the
      ICU, or until ICU discharge. Follow up is until ICU discharge. The primary outcome includes
      two main ventilator settings, i.e., tidal volume and the level of positive end-expiratory
      pressure. Secondary endpoints are development of ARDS in patients without ARDS at the onset
      of mechanical ventilation, worsening of ARDS in patients with ARDS at the onset of mechanical
      ventilation, pulmonary infection, other pulmonary complications, need for tracheostomy,
      duration of ventilation, length of ICU stay and ICU mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: scarce information exists on management of mechanical ventilation in intensive
      care unit (ICU) patients in low- and middle-income countries.

      Objective:The primary objective is to describe and compare ventilation management in patients
      at risk of ARDS versus individuals not at risk, and patients with established ARDS, and to
      ascertain whether certain ventilation settings are associated with a higher incidence of
      developing ARDS in patients in ICUs in Asia. PRoVENT-iMIC secondary objectives are to
      determine the epidemiological characteristics and clinical outcomes of patients at risk of
      ARDS in ICUs in Asia according to the ventilation practice applied.

      Primary hypothesis: a large proportion of patients at risk of ARDS in ICUs in Asia do not
      receive so-called protective ventilation, defined as tidal volume &lt; 8 ml/kg predicted body
      weight and a level of positive end-expiratory pressure of at least 5 cm H2O.

      Secondary hypothesis: in ICUs in Asia a large proportion of patients is at risk of ARDS, as
      stratified by a Lung Injury Prediction Score of ≥4.

      Study design: an international multicenter service review focusing on ICUs in selected
      middle-income Asian countries.

      Population: consecutive intubated and ventilated ICU patients.

      Methods: Patients in participating ICUs will be screened daily during a 28-day period. A
      registry of limited demographic data will be compiled on all screened patients. Collection of
      ventilation characteristics is restricted to the first three days. The first seven days or up
      to death, whichever comes first, will be used for collection of patient demographics (on day
      of admission), development of ARDS and other pulmonary complications. All patients will be
      followed until ICU-discharge to determine length of stay in ICU and ICU mortality. The
      inclusion period will be flexible for participating centers and determined at a later stage
      together with the study-coordinator. Data will be coded by a patient identification number of
      which the code will be kept safe at the local sites. The data will be transcribed by local
      investigators onto an internet based electronic case report form
      (https://www.project-redcap.org).

      Centers: about 60 Asian ICUs from ten countries are expected to participate in this
      international multicenter study. Each participating center will recruit ~ 50 patients.

      Ethics Approval: The Oxford Tropical Research Ethical Committee has evaluated the study and
      considered it exempt from ethical review on the 1st of June 2017. National coordinators will
      be responsible for clarifying the need for ethics approval and applying for this where
      appropriate according to local policy. Centers will not be permitted to record data unless
      ethics approval or an equivalent waiver is in place.

      Monitoring: Due to the observational nature of the study, a Data Safety and Monitoring Board
      is not necessary.

      Sample Size Calculation: a formal sample size calculation was not performed, seen the largely
      descriptive character of this investigation. 3000 patients are expected to be enrolled in the
      study period, which will be sufficient to test the hypotheses.

      Statistical Analysis: Patient characteristics will be compared and described by appropriate
      statistics. Student's t-test or Mann-Whitney U-tests are used to compare continuous variables
      and chi-squared tests are used for categorical variables. Data are expressed as means (SD),
      medians (interquartile range) and proportions as appropriate. Comparisons between and within
      groups are performed using one-way ANOVA and post-hoc analyses for continuous variables.

      The primary analysis concerns the determination of (variation of) tidal volume and PEEP
      levels in patients without ARDS. These are compared between predefined patient groups:
      patients at no risk for ARDS, patients at risk for ARDS, patients with mild ARDS, and
      patients with moderate or severe ARDS.

      To identify potential factors associated with outcome like development of ARDS, or worsening
      of ARDS, development of pulmonary complications, duration of ventilation, or death,
      univariate analyses are performed. A multivariate logistic regression model is used to
      identify independent risk factors. A stepwise approach is used to enter new terms into the
      model, with a limit of p &lt; 0.2 to enter the terms. Time to event variables are analyzed using
      Cox regression and visualized by Kaplan-Meier.

      Organization: The study is conducted by the PROtective VEntilation Network (PROVENet).
      National co-ordinators will lead the project within individual nations and identify
      participating hospitals, translate study paperwork, distribute study paperwork and ensure
      necessary regulatory approvals are in place. They provide assistance to the participating
      clinical sites in trial management, record keeping and data management. Local coordinators in
      each site will supervise data collection and ensure adherence to Good Clinical Practice
      during the trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tidal volume size</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>Tidal volume size in milliliters per kilogram of predicted body weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive end-expiratory pressure</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>Pressure in cm of water</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients at risk of ARDS</measure>
    <time_frame>On the date of inclusion</time_frame>
    <description>Risk of ARDS is stratified using the Lung Injury Prediction Score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspired Oxygen Concentration</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>expressed as fraction of inspired oxygen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plateau pressure</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>Pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak pressure</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>Peak away pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Driving pressure</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>in breaths per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minute Volume</measure>
    <time_frame>Day 1 to Day 3 from initiation of mechanical ventilation</time_frame>
    <description>expressed as liters per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of ARDS</measure>
    <time_frame>From date of inclusion until the date of first documented development of ARDS or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days</time_frame>
    <description>Development of ARDS in patients without ARDS at the onset of mechanical ventilation. Patients are defined as having ARDS if they meet the Berlin criteria for ARDS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worsening of ARDS</measure>
    <time_frame>From date of inclusion until the date of first documented worsening of ARDS or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days</time_frame>
    <description>Defined as any worsening in the degree of severity according to Berlin criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary infection</measure>
    <time_frame>From date of inclusion until the date of first documented pulmonary complication or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days</time_frame>
    <description>defined as need of new antibiotics in the presence of new or changed lung opacities on chest X-ray and/or new or changed sputum plus at least one of the following criteria: 1) temperature &gt; 38.3 ºC; or 2) WBC count &gt; 12,000</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other Pulmonary complications</measure>
    <time_frame>From date of inclusion until the date of first documented pulmonary complication or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days</time_frame>
    <description>pneumothorax, pleural effusions, cardiogenic pulmonary edema, new pulmonary infiltrates, and atelectasis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for tracheostomy</measure>
    <time_frame>From date of inclusion until the date of first documented tracheostomy procedure or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days</time_frame>
    <description>Need for tracheostomy during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>Until day 35 from study initiation</time_frame>
    <description>Time between admission and discharge or death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause ICU mortality</measure>
    <time_frame>Until day 35 from study initiation</time_frame>
    <description>Any death during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>Until day 35 from study initiation</time_frame>
    <description>time between orotracheal intubation and successful extubation;note: in case of intermittent MV via a tracheostomy, every day a patient needs MV counts as one extra day of MV, irrespective of duration of MV that specific day; in case of non-invasive ventilation (CPAP and/or BIPAP), the duration will be assessed separated from the assessment of invasive mechanical ventilation.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Mechanical Ventilation</condition>
  <condition>Respiratory Distress Syndrome, Adult</condition>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Mechanical Ventilation</arm_group_label>
    <description>Patients under mechanical ventilation in the ICU</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive intubated and ventilated intensive care unit patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to an ICU participating in this study

          -  Intubated in the ICU, or in the emergency room, general ward, or operation room before
             the present ICU admission

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Patients under invasive mechanical ventilation previous to the 28-day period of
             inclusion

          -  Patients transferred from another hospital under invasive mechanical ventilation

          -  Receiving only non-invasive ventilation (i.e., patient never received invasive
             ventilation during the present admission)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus J Schultz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Intensive Care, Academic Medical Center, University of Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arjen M Dondorp, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol Oxford Research Unit, University of Oxford</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luigi Pisani, MD</last_name>
    <role>Study Director</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ary Serpa Neto, MD, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Israelita Albert Einstein</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luigi Pisani, MD</last_name>
    <phone>+31683876341</phone>
    <email>luigipisani@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcus J Schultz, MD, PhD</last_name>
    <phone>+31-20-5662509</phone>
    <email>marcus.j.schultz@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chittagong Medical College Hospital</name>
      <address>
        <city>Chittagong</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alam Shamsul, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bangabandhu Sheikh Mujib Medical University</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Banik Debabrata, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BIRDEM General Hospital</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Areef Ahsan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dhaka Medical College Hospital</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mozzaffar Hussain, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mymensingh Medical College Hospital</name>
      <address>
        <city>Mymensingh</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fazlul Hog Pathan, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Abrar Al Sakib</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sulaiman Kabir</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rajshahi Medical College Hospital</name>
      <address>
        <city>Rajshahi</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abu Hena Mostafa Kamal, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sheikh Md Taher</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Taohidul Majid Taohid</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pranab Karmaker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rangpur Medical College Hospital</name>
      <address>
        <city>Rangpur</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hamidul Islam, MD</last_name>
    </contact>
    <investigator>
      <last_name>Feroz Ahmed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ziaul Hague</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Goutam Kumar Biswas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sylhet MAG Osmani Medical College Hospital</name>
      <address>
        <city>Sylhet</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabyasachi Roy, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Shantanu Das, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Nafees Imran</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mithun Chowdhury</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ispat General Hospital</name>
      <address>
        <city>Raurkela</city>
        <state>Odisha</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rajyabardhan Pattnaik, MD</last_name>
      <email>rajyapattnaik@yahoo.co.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. John's Medical College</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sriram Sampath, MD</last_name>
      <email>sriram.sampath123@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Bhuvana Krishna, MD</last_name>
      <email>bhuvana.11@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bharati Vidyapeeth Medical College</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shiva Iyer, MD</last_name>
      <email>suchetashiva@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shahid Beheshti University of Medical Sciences</name>
      <address>
        <city>Tehrān</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reza Hashemian, MD</last_name>
      <email>iran.criticalcare@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monash University</name>
      <address>
        <city>Johor Bahru</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nor'azim Mohd Yunos</last_name>
      <email>nor.azim@monash.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indira Gandhi Memorial Hospital</name>
      <address>
        <city>Malè</city>
        <country>Maldives</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hassan Moosa</last_name>
      <email>hmoosa@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allied Hospital</name>
      <address>
        <city>Faisalābad</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Joseph, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>PIMS</name>
      <address>
        <city>Islamabad</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Muneeb Ali, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shifa International Hospital</name>
      <address>
        <city>Islamabad</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaeysha Qadeer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aga Khan University Hospital MICU</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farah Idrees, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aga Khan University SICU</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madiha Hashmi</last_name>
      <email>madiha.hashmi@aku.edu</email>
    </contact>
    <investigator>
      <last_name>Saima Kamal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Patel Hospital</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sadaf Hanif, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doctor's Hospital</name>
      <address>
        <city>Lahore</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Farooq, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital and Medical Center</name>
      <address>
        <city>Lahore</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanveer Hussain, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fatima Jinnah Medical University</name>
      <address>
        <city>Nawabshah</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saleh Khaskheli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North West General Hospital</name>
      <address>
        <city>Peshawar</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Hayat, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sri Jayewardenepura General Hospital</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Chulalongkorn University Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Napplika Kongpolprom, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mahidol Oxford Research Unit</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prapaportn Pornsuriyasak, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tananchai Petnak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pongsasit Singhatas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Viratch Tangsujaritvijit, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chiang Mai Hospital Surgical ICU</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Chiang Mai Medical ICU</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hatyai Hospital</name>
      <address>
        <city>Hat Yai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chutima Cheranakhorn, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nitchakarn Nakhwan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prince of Songkla University</name>
      <address>
        <city>Hat Yai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunisa Chatmongkolcart, Ass. Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Rungsun Bhurayanontachai, Ass. Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Osaree Akaraborwon, Ass. Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asma Navasakulpong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Srinakharinwirot University</name>
      <address>
        <city>Ongkharak</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suthat Rungruanghiranya, Ass. Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Udonthani Regional Hospital</name>
      <address>
        <city>Udon Thani</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hathairawee Hawharn, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Soraya Luanchan, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Oxford University Clinical Research Unit</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louise Thwaites, MD</last_name>
      <email>lthwaites@oucru.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Bangladesh</country>
    <country>India</country>
    <country>Iran, Islamic Republic of</country>
    <country>Malaysia</country>
    <country>Maldives</country>
    <country>Pakistan</country>
    <country>Sri Lanka</country>
    <country>Thailand</country>
    <country>Vietnam</country>
  </location_countries>
  <link>
    <url>https://sites.google.com/site/proventimic/</url>
    <description>Study website</description>
  </link>
  <link>
    <url>https://sites.google.com/site/proveneteu/</url>
    <description>Protective Ventilation Network website</description>
  </link>
  <reference>
    <citation>Serpa Neto A, Cardoso SO, Manetta JA, Pereira VG, Espósito DC, Pasqualucci Mde O, Damasceno MC, Schultz MJ. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012 Oct 24;308(16):1651-9. doi: 10.1001/jama.2012.13730.</citation>
    <PMID>23093163</PMID>
  </reference>
  <results_reference>
    <citation>Neto AS, Barbas CSV, Simonis FD, Artigas-Raventós A, Canet J, Determann RM, Anstey J, Hedenstierna G, Hemmes SNT, Hermans G, Hiesmayr M, Hollmann MW, Jaber S, Martin-Loeches I, Mills GH, Pearse RM, Putensen C, Schmid W, Severgnini P, Smith R, Treschan TA, Tschernko EM, Melo MFV, Wrigge H, de Abreu MG, Pelosi P, Schultz MJ; PRoVENT; PROVE Network investigators. Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study. Lancet Respir Med. 2016 Nov;4(11):882-893. doi: 10.1016/S2213-2600(16)30305-8. Epub 2016 Oct 4.</citation>
    <PMID>27717861</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Marcus J. Schultz</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Middle-income countries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

